| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RNF213 antisense RNA 1 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2011 | 2011 | |||||||||
|
microRNA 6722 | 0.931 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
coiled-coil glutamate rich protein 2 | 0.931 | 0.077 | 4.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
TSC22 domain family member 2 | 0.861 | 0.154 | 0.97 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
dedicator of cytokinesis 9 | 0.769 | 0.192 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
sphingomyelin phosphodiesterase acid like 3B | 0.861 | 0.192 | 2.4E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
Malignant mesothelioma, susceptibility to | 0.792 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
F-box protein 25 | 0.839 | 0.269 | 2.0E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
opioid growth factor receptor | 0.678 | 0.308 | 3.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
DNA fragmentation factor subunit alpha | 0.663 | 0.385 | 8.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ubiquitin specific peptidase 15 | 0.711 | 0.423 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
BRCA1/BRCA2-containing complex subunit 3 | 0.686 | 0.500 | 6.4E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
GEN1 Holliday junction 5' flap endonuclease | 0.682 | 0.500 | 3.7E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ring finger protein 213 | 0.628 | 0.538 | 4.9E-55 |
|
disease | 0.500 | None | 0.962 | 80 | 7 | 2011 | 2020 | ||||||||
|
Rap guanine nucleotide exchange factor 4 | 0.647 | 0.538 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ecdysoneless cell cycle regulator | 0.656 | 0.538 | 2.3E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.736 | 0.538 | 1.9E-164 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
guanylate cyclase 1 soluble subunit alpha 1 | 0.686 | 0.577 | 3.1E-08 |
|
disease | 0.120 | None | 1.000 | 2 | 3 | 2016 | 2017 | ||||||||
|
monocyte to macrophage differentiation associated | 0.647 | 0.577 | 1.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
SET binding factor 2 | 0.619 | 0.577 | 6.4E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
growth control, Y chromosome influenced | 0.631 | 0.615 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2019 | |||||||||
|
craniofacial development protein 1 | 0.619 | 0.615 | 3.7E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
spectrin alpha, non-erythrocytic 1 | 0.601 | 0.615 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
transcobalamin 2 | 0.578 | 0.615 | 1.0E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 |